PRA Health Sciences (PRAH) Reports In-Line Q3 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts PRAH Hot Sheet
Join SI Premium – FREE
PRA Health Sciences (NASDAQ: PRAH) reported Q3 EPS of $0.64, in-line with the analyst estimate of $0.64. Revenue for the quarter came in at $399.8 million versus the consensus estimate of $394.87 million.
GUIDANCE:
PRA Health Sciences sees FY2016 EPS of $2.45-$2.48, versus the consensus of $2.47.
For earnings history and earnings-related data on PRA Health Sciences (PRAH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Southwest Gas (SWX) Tops Q3 EPS by 2c; Offers Guidance
- Scotts Miracle-Gro (SMG) Tops Q4 EPS by 5c ; Offers Guidance
- Studio City International Holdings Limited (MSC) Reports Q3 Loss of $0.02
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
